Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by KTDfyion Apr 23, 2023 11:33am
146 Views
Post# 35409304

RE:Let’s keep the information as real as we can…why not

RE:Let’s keep the information as real as we can…why not Canadafan keep up the good work. I for one really appreciate some common sense and the factual information that you are providing. Of course I'd like things to happen sooner rather than later. I think that's just human nature. There is risk, yet I feel that the risk has substantially reduced. I'm expecting good data. I think there are many reasons for the SP being where it is. As a company with the patents and all the trials to date, I feel, means that they want the results to be shown. I wouldn't be surprised if there's been offers, that's why the data becomes so important. As far as the timelines, don't know. Keep up the good work. I appreciate it. 
<< Previous
Bullboard Posts
Next >>